Communiqués
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
![](https://phaxiam.com/wp-content/uploads/2023/06/Capture-decran-2023-09-11-a-12.11.36.png)
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance (AMR).